Journal: Biosensors
Article Title: A Bioelectronic System to Measure the Glycolytic Metabolism of Activated CD4+ T Cells
doi: 10.3390/bios9010010
Figure Lengend Snippet: Inhibitors of PI3K (LY294002) and mTORC1 (temsirolimus) suppress glucose uptake and lactate production by activated CD4+ T cells. CD4+ T cells were purified by negative selection from HIV-healthy donors, stimulated (as described in the legend of ) with PMA, ionomycin, and IL-2 (5 ng/mL) for 48 h, replaced with fresh media, and then left untreated (UT) or treated with either LY294002 (15 uM), temsirolimus (100 nM), or SB201290 (10 uM, p38 inhibitor). ( A ) Viability of the CD4+ T cells as measured by trypan blue exclusion assay. ( B ) Data showing the amount of glucose taken up by the CD4+ T cells in culture using the GlucMeter. ( C ) 2-NBDG uptake by the CD4+ T cells as measured using flow cytometry. ( D ) L-lactate levels in CD4+ T cell culture medium, measured using an L-lactate assay kit as described in the . All experiments were conducted in duplicates, with three independent experiments. The paired T-test was used to determine significant treatments between the treatments.
Article Snippet: The CD4+ T cells were purified from thawed PBMCs from healthy donors using the Human EasySep CD4+ T cell enrichment kit (Stem Cell, Technology Inc, Vancouver, BC, Canada).
Techniques: Purification, Selection, Trypan Blue Exclusion Assay, Flow Cytometry, Cell Culture, Lactate Assay